Cimicoxib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCimicoxib
Drug Alias Namecimicoxibum西米考昔西咪昔布UR-8880
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaAustriaGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAffectis Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffectis Pharmaceuticals Ag
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank